Diagnosis and treatment of bacterial meningitis

Archives of Disease in Childhood

Volumn 88, Issue 7, 2003, Pages 615-620

  El Bashir, H ^a,b   Laundy, M ^b   Booy, R ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DEXAMETHASONE; GATIFLOXACIN; GLYCEROL; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMIPENEM; INFUSION FLUID; MANNITOL; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SODIUM CHLORIDE; STEROID; TROVAFLOXACIN; VANCOMYCIN; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DEHYDRATION; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFANT; INTRACRANIAL HYPERTENSION; LABORATORY DIAGNOSIS; LUMBAR PUNCTURE; MENINGOCOCCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SYMPTOMATOLOGY; FLUID THERAPY; METHODOLOGY; PRESCHOOL CHILD; PUNCTURE;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DRUG RESISTANCE, BACTERIAL; FLUID THERAPY; GLUCOCORTICOIDS; HUMANS; INFANT; INTRACRANIAL HYPERTENSION; MENINGITIS, BACTERIAL; SPINAL PUNCTURE;

EID: 0038168663     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.7.615     Document Type: Review

References (79)

1. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992;11:694-8.
2. Thomas KE, Hasbun R, Jekel J, et al. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis 2002;35:46-52.
3. Kneen R, Solomon T, Appleton R. The role of lumbar puncture in suspected CNS infection - a disappearing skill? Arch Dis Child 2002;87:181-3.
4. Riordan FAI, Cant AJ. When to do a lumbar puncture. Arch Dis Child 2002;87:235-7.
5. Nadel S. Lumbar puncture should not be performed in meningococcal disease. Arch Dis Child 2001;84:375.
6. Addy DP. When not to do a lumbar puncture. Arch Dis Child 1987;62:873-5.
7. Sam WI. The role of lumbar puncture in meningococcal disease. Arch Dis Child 2000;83:370.
8. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 2001;108:1169-74.
9. Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000;105:316-19.
10. Perkins MD, Mirrett S, Reller LB. Rapid bacterial antigen detection is not clinically useful. J Clin Microbiol 1995;33:1486-91.
11. Barnes RA, Jenkins P, Coakley WT. Preliminary clinical evaluation of meningococcal disease and bacterial meningitis by ultrasonic enhancement. Arch Dis Child 1998;78:58-60.
12. Haslam RH. Role of computed tomography in the early management of bacterial meningitis. J Pediatr 1991;119:157-9.
13. Shetty AK, Desselle BC, Craver RD, et al. Fatal cerebral herniation after lumbar puncture in a patient with a normal computed tomography scan. Pediatrics 1999;103:1284-7.
14. Cabral DA, Flodmark O, Farrell K, et al. Prospective study of computed tomography in acute bacterial meningitis. J Pediatr 1987;111:201-5.
15. Cartwright K, Kroll S. Optimising the investigation of meningococcal disease. BMJ 1997;315:757-8.
16. van Deuren M, van Dijke BJ, Koopman RJ, et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 1993;306:1229-32.
17. Taylor MR, Keane CT, Periappuram M. Skin scraping is a useful investigation in meningococcal disease. BMJ 1997;314:831-2.
18. Hackett SJ, Carrol ED, Guiver M, et al. Improved case confirmation in meningococcal disease with whole blood Taqman PCR. Arch Dis Child 2002;86:449-52.
19. Carrol ED, Thomson AP, Shears P, et al. Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch Dis Child 2000;83:271-3.
20. Borrow R, Claus H, Guiver M, et al. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect 1997;118:111-17.
21. Hackett SJ, Guiver M, Marsh J, et al. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 2002;86:44-6.
22. Cherian T, Lalitha MK, Manoharan A, et al. PCR-enzyme immunoassay for detection of Streptococcus pneumoniae DNA in cerebrospinal fluid samples from patients with culture-negative meningitis. J Clin Microbiol 1998;36:3605-8.
23. Dagan R, Shriker O, Hazan I, et al. Prospective study to determine clinical relevance of detection of pneumococcol DNA in sera of children by PCR. J Clin Microbiol 1998;36:669-73.
24. Cherubin CE, Marr JS, Sierra MF, et al. Listeria and gram-negative bacillary meningitis in New York City, 1972-1979: frequent causes of meningitis in adults. Am J Med 1981;71:199-209.
25. Scheld WM, Sande MA. Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest 1983;71:411-19.
26. Sande MA. Factors influencing the penetration and activity of antibiotics in experimental meningitis. J Infect 1981;3(suppl):33-8.
27. Tauber MG, Sande MA. General principles of therapy of pyogenic meningitis. Infect Dis Clin North Am 1990;4:661-76.
28. Tauber MG, Doroshow CA, Hackbarth CJ, et al. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis 1984;149:568-74.
29. Strausbaugh LJ, Sande MA. Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. J Infect Dis 1978;137:251-60.
30. Friedlond IR, Jafari H, Ehrett S, et al. comparison of endotoxins release by different antimicrobial agents and the effect of inflammation in experimental Escherichia coli meningitis. J Infect Dis 1993;168:657-62.
31. Behrman RE, Kliegman RM, Arvin AM. Nelson textbook of pediatrics, 15th edn. W B Saunders, 1996.
32. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997;336:708-16.
33. Frenkel LD, and the Multicentre Ceftriaxone Pediatric Study Group. Once-daily administration of ceftriaxone for the treatment of selected bacterial infections in children. Pediatrics 1988;82:486-91.
34. Roine I, Ledermann W, Foncea LM, et al. Randomised trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery. Pediatr Infect Dis J 2000;19:219-22.
35. Begg N, Cartwright KA, Cohen J, et al. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. J Infect 1999;39:1-15.
36. Bottcher T, Gerber J, Wellmer A, et al. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis 2000;181:2095-8.
37. Nau R, Wellmer A, Soto A, et al. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis 1999;179:1557-60.
38. Pikis A, Donkersloot JA, Akram S, et al. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 1997;40:105-8.
39. Paris MM, Hickey S, Uscher MI, et al. Evaluation of CP-99,219, a new fluoroquinolone, for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1995;39:1243-6.
40. Schmidt H, Dalhoff A, Stuertz K, et al. Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob Agents Chemother 1998;42:1397-407.
41. Fenoll A, Martin Bourgon C, Munoz R, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991;13:56-60.
42. Marton A, Gulyas M, Munoz R, et al. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991;163:542-8.
43. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920-3.
44. Yoshida R, Kaku M, Kohno S, et al. Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan. Antimicrob Agents Chemother 1995;39:1196-8.
45. Jones RN, Kehrberg E, Erwin ME, et al. Epidemiologic studies of emerging antimicrobial resistance in USA hospitals: report from a forty medical centre surveillance of parenteral drug susceptibility. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 4-7 October 1994. Washington, DC: American Society for Microbiology, 1994:87.
46. Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-16.
47. Friedland IR, McCracken GH. Management of infections caused by antibiotic resistant Streptococcus pneumoniae. J Infect Dis 1984;149:568-74.
48. Coffey TJ, Daniels M, McDougal LK, et al. Genetics analysis of clinical isolates of Streptococcus pneumoniae with high level resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1995;39:1306-13.
49. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991;35:2467-72.
50. Friedland IR, Paris M, Ehertt S, et al. Evaluation of antimicrobial regimens for treatment of experimental penicillin and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993;37:1630-6.
51. McMaster P, McIntyre P, Gilmour R, et al. The emergence of resistant pneumococcal meningitis - implications for empiric therapy. Arch Dis Child 2002;87:207-11.
52. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, ed. Red Book: Report of the Committee on Infectious Diseases, 25th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2000:452-60.
53. Dillon JR, Pauze M, Yeung K-H. Spread of penicillinase-producing and transfer plasmids from gonococcus to Neisseria meningitidis. Lancet 1983;1:779-81.
54. Woods CR, Smith AL, Wasilauskas BL, et al. Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina. J Infect Dis 1994;170:453-6.
55. Prince AS, Neu HC. Fluid management in Hameophilus influenzae meningitis. Infection 1980;8:5-7.
56. Singhi SC, Singhi PD, Srinivas B, et al. Fluid restriction does not improve the outcome of acute meningitis. Pediatr Infect Dis J 1995;14:495-503.
57. Tauber MG, Sande E, Fournier MA, et al. Fluid administration, brain oedema, and cerebrospinal fluid lactate and glucose concentration in experimental Escherichia coli meningitis. J Infect Dis 1993;168:473-6.
58. Duke T, Mokela D, Frank D, et al. Management of meningitis in children with oral fluid restriction or intravenous fluid at maintenance volumes: a randomised trial. Ann Trop Paediatr 2002;22:145-57.
59. Kaplan SL, Feigin RD. The syndrome of inappropriate secretion of antidiuretic hormone in children with bacterial meningitis. J Pediatr 1978;92:758-61.
60. Bianchetti MG, Thyssen HR, Laux-End R, et al. Evidence for fluid volume depletion in hyponatraemic patients with bacterial meningitis. Acta Paediatr 1996;85:1163-6.
61. Kato K, Yokoi T, Takano N, et al. Detection by in situ hybridisation and phenotypic characterisation of cells expressing IL-6 m RNA in human stimulated blood. J Immunol 1990;144:1317-22.
62. Fishman RA. Steroids in the treatment of brain edema. N Engl J Med 1982;306:359-60.
63. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
64. Lepper MH, Spies HW. Treatment of pneumococci meningitis. Arch Intern Med 1958;104:252-9.
65. Havens P, Wendelberger KJ, Hofman GM, et al. Corticosteroid as adjunctive therapy in bacterial meningitis. Am J Dis Child 1989;143:1051-5.
66. Geiman BJ, Smith AL. Dexamethasone and bacterial meningitis: a meta-analysis of randomised controlled trials. West J Med 1992;157:27-31.
67. Krysan D, Kemper AR. Claims of equivalence in randomized controlled trials of the treatment of bacterial meningitis in children. Pediatr Infect Dis J 2002;21:753-7.
68. Kennedy WA, Hoyt MJ, McCracken GH Jr. The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child 1991;145:1374-8.
69. Kanra GY, Ozen H, Secmeer G, et al. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995;14:490-4.
70. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989;6:848-51.
71. Schaad UB, Lips U, Gnehm HE, et al. Dexamethasone therapy for bacterial meningitis in children. Lancet 1993;342:457-61.
72. Friedland IR, Paris MM, Ehrett S, et al. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993;37:1630-6.
73. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995;39:1988-92.
74. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360:211-17.
75. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-31.
76. Levin M, Walters MDS. Infections of the nervous system. In: Brett EM, ed. Paediatric neurology, 3rd edn. Edinburgh: Churchill Livingstone, 1997:632-3.
77. Pickard JD, Czosnyka M. Raised intracranial pressure. In: Hughes RAC, ed. Neurological emergencies, 3rd edn. London: BMJ Publishing Group, 2000:173-218.
78. Band JD, Fraser DW, Ajello G, Haemophilus Influenzae Disease Study Group. Prevention of Haemophilus influenzae type b disease. JAMA 1984;251:2381-6.
79. Public Health Laboratory Service Meningococcus Forum. Guidelines for public health management of meningococcal disease in the UK. Commun Dis Public Health 2002;5:184-204.